DHI vs LRMR · P/E 9.6, rev $34.25B vs $204.9M cap
DR Horton Inc (DHI) versus Larimar Therapeutics Inc (LRMR) — a side-by-side from cached financials, not a winner call.
DR Horton Inc (DHI) is a residential construction company listed on US.
Larimar Therapeutics Inc (LRMR) is a biotechnology company listed on US.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
LRMR does not have a complete income-statement cache yet.
DHI currently screens at market cap $39.10B and trailing P/E 9.6. LRMR currently screens at market cap $204.9M.
Not investment advice. Open the DHI and LRMR stock pages for the full models.
Not investment advice.